Research and Development
This unique technology is registered with the FDA in the US as a Class 1 Device, and has been granted three distinct U.S. patents as a low-frequency acoustic methodology for pain application.
Sonix Health is currently conducting multiple studies on diabetic neuropathy and rheumatoid arthritis.
University pilot studies indicate over 85% of Medsonix therapy recipient’s experienced symptomatic improvement and no negative side effects, with only one application.
Below are some examples of research into low frequency sound wave application.